Satinsky A et al., 2026-07: Case report of liver injury from fenbendazole taken together with tauroursodeoxycholic acid, which the patient used intending to protect the liver; the authors describe it as the first published report of that combination.
We present a case of fenbendazole-associated DILI with concomitant use of tauroursodeoxycholic acid as an intended hepatoprotective agent.
Abstract
Satinsky A et al., 2026-07: Case report of liver injury from fenbendazole taken together with tauroursodeoxycholic acid, which the patient used intending to protect the liver; the authors describe it as the first published report of that combination. Study type: single case report, n=1, USA. Dose, schedule and duration not stated in the abstract captured. Route oral. Other treatment: tauroursodeoxycholic acid as a self-prescribed hepatoprotective. Outcome: drug-induced liver injury attributed to fenbendazole. Funding and conflicts: not stated in the record. Comparator: none. Also filed as FBE-28 (claims C2, C3). Study type: case report.
